Genotypic and phenotypic characteristics of Tunisian isoniazid-resistant Mycobacterium tuberculosis strains

Journal of Microbiology

Volumn 49, Issue 3, 2011, Pages 413-417

  Soudani, Alya ^a   Hadjfredj, Sondess ^b   Zribi, Meriem ^a   Messaadi, Feriel ^c   Messaoud, Taieb ^b   Masmoudi, Afef ^a   Zribi, Mohamed ^c   Fendri, Chedlia ^a  

^a LA RABTA HOSPITAL   (Tunisia)

^b CHILDREN S HOSPITAL   (Tunisia)

^c HEDI CHAKER HOSPITAL   (Tunisia)

Author keywords

isoniazid resistance; katG315 and mabA 15C T mutations; M. tuberculosis; new katG326 mutation; phenotypic properties

Indexed keywords

BACTERIAL PROTEIN; CATALASE; ISONIAZID; KATG PROTEIN, MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSTATIC AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CLASSIFICATION; DNA SEQUENCE; DRUG EFFECT; ENZYMOLOGY; GENETICS; GENOTYPE; HUMAN; METABOLISM; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MOLECULAR GENETICS; MULTIDRUG RESISTANCE; MULTIDRUG RESISTANT TUBERCULOSIS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; TUNISIA;

ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CATALASE; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; HUMANS; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; MUTATION; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUNISIA;

MYCOBACTERIUM TUBERCULOSIS;

EID: 79959738736     PISSN: 12258873     EISSN: 12258873     Source Type: Journal    
DOI: 10.1007/s12275-011-0268-1     Document Type: Article

References (33)

1. Abate, G., S. E. Hoffner, V. O. Thomsen, and H. Miörner. 2001. Characterization of isoniazid-resistant strains of Mycobacterium tuberculosis on the basis of phenotypic properties and mutations in katG. Eur. J. Clin. Microbiol. Infect. Dis. 20, 329-333.
2. Banerjee, A., E. Dubnau, A. Quemard, V. Balasubramanian, K. SunUm, T. Wilson, D. Collins, G. de Lisle, and W. R. Jacobs, Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamid in Mycobacterium tuberculosis. Science 263, 227-230.
3. Buck, G. E., L. C. O'Hara, and J. T. Summersgill. 1992. Rapid, simple method for treating clinical specimens containing Mycobacterium tuberculosis to remove DNA for polymerase chain reaction. J. Clin. Microbiol. 30, 1331-1334.
4. Canetti, G., W. Fox, and A. Khomenko. 1969. Advances in techniques of testing mycobacterial drug sensitivity, and the use of sensitivity tests in tuberculosis control programs. Bull. WHO 41, 21-43.
5. Dobner, P., S. Rüsch-Gerdes, G. Bretzel, K. Feldmann, M. Rifai, T. Löscher, and H. Rinder. 1997. Usefulness of Mycobacterium tuberculosis genomic mutations in the katG and inhA for the prediction of isoniazid resistance. Int. J. Tuberc. Lung Dis. 1, 365-369.
6. Guo, H., Q. Seet, S. Denkin, L. Parsons, and Y. Zhang. 2006. Molecular characterization of isoniazid-resistant isolates of Mycobacterium tuberculosis from USA. J. Med. Microbiol. 55, 1527-1531.
7. Haas, W. H., K. Schilke, J. Brand, B. Amthor, K. Weyer, P. B. Fourie, G. Bretzel, V. Sticht-Groh, and H. J. Bremer. 1997. Molecular analysis of katG gene mutations in strains of Mycobacterium tuberculosis complex from Africa. Antimicrob. Agents Chemother. 41, 1601-1603.
8. Hazbóm, M. H., M. Brimacombe, M. Bobadilla del Valle, M. Cavatore, M. I. Guerrero, M. Varma-Basil, H. Billman-Jacobe, and et al. 2006. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 50, 2640-2649.
9. Hillemann, D., T. Kubica, R. Agzamova, B. Venera, S. Rüsch-Gerdes, and S. Niemann. 2005. Rifampicin and isoniazid resistance mutations in Mycobacterium tuberculosis strains isolated from patients in Kazakhstan. Int. J. Tuberc. Lung. Dis. 9, 1161-1167.
10. Kent, P. T. and G. P. Kubica. 1985. Public health mycobacteriology. A guide for the level III laboratory. US Department of Health and Services, Centers for Disease and Control, Atlanta, USA.
11. Lavender, C., M. Globan, A. Sievers, H. Billman-Jacobe, and J. Fyfe. 2005. Molecular characterization of isoniazid-resistant Mycobacterium tuberculosis isolates collected in Australia. Antimicrob. Agents Chemother. 49, 4068-4075.
12. Lee, H. S. N., H. E. Bang, J. H. Lee, G. H. Bai, S. J. Kim, and J. D. Kim. 2000. Exclusive mutations related to isoniazid and ethionamide resistance among Mycobacterium tuberculosis isolates from Korea. Int. J. Tuberc. Lung Dis. 4, 441-447.
13. Lee, A. S. G., I. H. K. Lim, L. L. H. Tang, A. Telenti, and S. Y. Wong. 1999. Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrob. Agents Chemother. 43, 2087-2089.
14. Madison, B. M., S. H. Siddiqi, L. Heifets, W. Gross, M. Higgins, N. Warren, A. Thompson, G. Morlock, and J. C. Ridderhof. 2004. Identification of a Mycobacterium tuberculosis strain with stable, low-level resistance to isoniazid. J. Clin. Microbiol. 42, 1294-1295.
15. Marttila, H. J., H. Soini, E. Eerola, E. Vyshnevskaya, B. I. Vyshnevskiy, T. F. Otten, A. V. Vasilyef, and M. K. Viljanen. 1998. A Ser315Thr substitution in katG is predominant in genetically heterogeneous multidrug-resistant Mycobacterium tuberculosis isolates originating from the St. Petersburg area in Russia. Antimicrob. Agents Chemother. 42, 2443-2445.
16. Mdluli, K., R. A. Slayden, Y. Q. Zhu, S. Ramaswamy, X. Pan, D. Mead, D. D. Crane, J. M. Musser, and C. E. Barry, III. 1998. Inhibition of a Mycobacterium tuberculosis b-ketoacyl ACP synthase by isoniazid. Science 280, 1607-1610.
17. Middlebrook, G. 1954. Isoniazid-resistance and catalase activity of tubercle bacilli. Am. Rev. Tuberc. 69, 471-472.
18. Mokrousov, I., O. Narvskaya, T. Otten, E. Limeschenko, L. Steklova, and B. Vyshnevskiy. 2002a. High prevalence of katG Ser315Thr susbstitution among isoniazid-resistant Mycobacterium tuberculosis clinical isolates from Northwestern Russia, 1996 to 2001. Antimicrob. Agents Chemother. 46, 1417-1424.
19. Mokrousov, I., T. Otten, M. Filipenko, A. Vyazovaya, E. Chrapov, E. Limeschenko, L. Steklova, B. Vyshnevskiy, and O. Narvskaya. 2002b. Detection of isoniazid-resistant Mycobacterium tuberculosis strains by a multiplex allele-sepecific PCR assay targeting katG codon 315 variation. J. Clin. Microbiol. 40, 2509-2512.
20. Musser, J. M., V. Kapur, D. L. Williams, B. N. Kreiswirth, D. van Soolingen, and J. D. A. van Embeden. 1996. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazidresistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: Restricted array of mutations associated with drug resistance. J. Infect. Dis. 173, 196-202.
21. Piatek, A. S., A. Telenti, M. R. Murray, H. El-Hajj, W. R. Jacobs, Jr., F. R. Kramer, and D. Alland. 2000. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: Implications for rapid susceptibility testing. Antimicrob. Agents Chemother. 44, 103-110.
22. Pym, A. S., B. Saint-Joanis, and S. T. Cole. 2002. Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect. Immun. 70, 4955-4960.
23. Ramaswamy, S. and J. M. Musser. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuberc. Lung Dis. 79, 3-29.
24. Ramaswamy, S. V., R. Reich, S. J. Dou, L. Jasperse, X. Pan, A. Wanger, T. Quitugua, and E. A. Graviss. 2003. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 47, 1241-1250.
25. Rouse, D. A., Z. Li, G. H. Bai, and S. L. Morris. 1995. Characterization of the katG and inhA genes of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 39, 2472-2477.
26. Silva, M. S. N., S. G. Senna, M. O. Ribeiro, A. R. M. Valim, M. A. Telles, A. Kritski, G. P. Morlock, R. C. Cooksey, A. Zaha, and M. L. R. Rossetti. 2003. Mutations in katG, inhA, and aphC genes of Brazilian isoniazid-resistant isolates of Mycobacterium tuberculosis. J. Clin. Microbiol. 41, 4471-4474.
27. Slim, L., F. Tritar, W. Mahjoubi, R. Mehouachi, D. Belhabib, I. Drira, H. Ghedira, and R. Jebeniani. 2004. Prospective study of Mycobacterium tuberculosis drug resistance in Tunisia. Eur. Respir. J. 24, supl. 48, 658S.
28. van Rie, A., R. Warren, I. Mshanga, A. Jordaan, G. D. van der Spuy, M. Richardson, J. Simpson, and et al. 2001. Analysis for a limited number of gene codons can predict drug resistance of Mycobacterium tuberculosis in a high-incidence community. J. Clin. Microbiol. 39, 636-641.
29. van Soolingen, D., P. E. W. de Haas, H. R. vanDoorn, Ed. Kuijper, H. Rinder, and M. W. Borgdorff. 2000. Mutations at amino acid position 315 of the katG gene are associated with high-level resistance to isoniazid, other drug resistance, and successful transmission of Mycobacterium tuberculosis in the Netherlands. J. Infect. Dis. 182, 1788-1790.
30. Wilson, T. M. and D. M. Collins. 1996. aphC, a gene involved in isoniazid resistance of the Mycobacterium tuberculosis complex. Mol. Microbiol. 19, 1025-1034.
31. World Health Organisation: WHO Report 2008, Global Tuberculosis Control: Surveillance, Planning, Financing. WHO/HTM/TB/2008. 393.
32. Yang, Z., R. Durmaz, D. Yang, S. Gunal, L. Zhang, B. Foxman, A. Sanic, and C. F. Marrs. 2005. Simultaneous detection of isoniazid, rifampicin, and ethambutol resistance of Mycobacterium tuberculosis by a single multiplex allele-specific polymerase chain reaction (PCR) assay. Diagn. Microbiol. Infect. Dis. 53, 201-208.
33. Zhang, Y., B. Heym, B. Allens, D. Young, and S. Cole. 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358, 591-593.